CIK 0001585364
- Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +1 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-03 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Option exercise · Restricted Stock Units | −1,542 | 0 | ||
| 2023-03-03 | Janish Ronald Craig EVP, Gbl Ops & SC & CTO | Option exercise · Restricted Stock Units | −2,071 | 2,071 | ||
| 2023-03-03 | Willis Robert EVP & CHRO | Grant or award | +4,905 | $38.75 | $190K | 13,999 |
| 2023-03-03 | Willis Robert EVP & CHRO | Shares withheld for taxes | −2,551 | $38.75 | $99K | 11,448 |
| 2023-03-03 | Willis Robert EVP & CHRO | Option exercise | +952 | $38.75 | $37K | 12,400 |
| 2023-03-03 | Willis Robert EVP & CHRO | Shares withheld for taxes | −496 | $38.75 | $19K | 11,904 |
| 2023-03-03 | Willis Robert EVP & CHRO | Option exercise | +1,279 | $38.75 | $50K | 13,183 |
| 2023-03-03 | Willis Robert EVP & CHRO | Shares withheld for taxes | −666 | $38.75 | $26K | 12,517 |
| 2023-03-03 | Willis Robert EVP & CHRO | Option exercise · Restricted Stock Units | −952 | 0 | ||
| 2023-03-03 | Willis Robert EVP & CHRO | Option exercise · Restricted Stock Units | −1,279 | 1,279 | ||
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Grant or award | +5,419 | $38.75 | $210K | 14,537 |
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −2,818 | $38.75 | $109K | 11,719 |
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +1,052 | $38.75 | $41K | 12,771 |
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −548 | $38.75 | $21K | 12,223 |
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +1,584 | $38.75 | $61K | 13,807 |
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −824 | $38.75 | $32K | 12,983 |
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −1,052 | 0 | ||
| 2023-03-03 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −1,584 | 1,583 | ||
| 2022-12-16 | Quinn Grainne EVP, Chief Medical Officer | Sale | −2,368 | $31.65 | $75K | 9,118 |
| 2022-10-07 | Ives Alison EVP & Chief Scientific Officer | Option exercise | +739 | $38.09 | $28K | 4,973 |
Page 29 of 47 · 921 trades